Singapore vs Switzerland: Proportion of the target population who received
Singapore
93.0%
in 2024
Switzerland
93.0%
in 2024
Singapore rank
49th
Switzerland rank
49th
Proportion of the target population who received over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 93.0% against 93.0% in Switzerland, a difference of 0.0%.
The two have swapped places 5 times across 20 shared years of data; in 2005 it was Singapore ahead.
Singapore ranks 49th and Switzerland ranks 49th of 193 countries.
Across the 3 decades both report, Singapore averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.8% | 75.8% | 20.0% | Singapore |
| 2010s | 91.8% | 87.2% | 4.6% | Singapore |
| 2020s | 92.8% | 93.0% | 0.2% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Singapore or Switzerland?
- Singapore, at 93.0% against 93.0% in Switzerland as of 2024.
- What is the difference in proportion of the target population who received between Singapore and Switzerland?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 20 years are reported by both, from 2005 to 2024.
- How do Singapore and Switzerland rank globally for proportion of the target population who received?
- Singapore ranks 49th and Switzerland ranks 49th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.